Literature DB >> 30178846

MiR-363-3p modulates cell growth and invasion in glioma by directly targeting pyruvate dehydrogenase B.

D-X Xu1, J-J Guo, G-Y Zhu, H-J Wu, Q-S Zhang, T Cui.   

Abstract

OBJECTIVE: This study is designed to investigate the role of miR-363-3p in the cancer development of glioma. PATIENTS AND METHODS: The expression of miR-363-3p in glioma and adjacent noncancerous tissue was measured using quantitative RT-PCR. The expression of a target gene of miR-363-3p, pyruvate dehydrogenase B (PDHB), was determined by Western blot. The level of miR-363-3p was increased or decreased by transfected with miR-363-3p mimic or miR-363-3p inhibitor, respectively. The impact of miR-363-3p on cell growth, apoptosis and invasion was determined by CCK-8 (Cell Counting Kit) assay, flow cytometry, and transwell assay. The role of PDHB in mediating the oncogenic activities was demonstrated by co-transfected PDHB vector and miR-363-3p mimic.
RESULTS: Our results have shown that miR-3663-3p level was significantly higher in glioma tissue. Furthermore, miR-363-3p functions as onco-miRNA, promotes cell proliferation, protects against apoptosis, and enhances invasion by directly targeting PDHB.
CONCLUSIONS: MiR-363-3p is an onco-miRNA, which can be considered as a potential therapeutic target in glioma.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30178846     DOI: 10.26355/eurrev_201808_15721

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  miR-363-3p induces EMT via the Wnt/β-catenin pathway in glioma cells by targeting CELF2.

Authors:  Bo Fan; Bolun Su; Guoqiang Song; Xin Liu; Zhongjie Yan; Shuai Wang; Fuguang Hu; Jiankai Yang
Journal:  J Cell Mol Med       Date:  2021-10-12       Impact factor: 5.310

2.  miR-145-5p inhibits the proliferation of glioma stem cells by targeting translationally controlled tumor protein.

Authors:  Qiujian Zhang; Zhe Cheng; Lei Shi; Gengsheng Mao
Journal:  J Cancer       Date:  2022-02-28       Impact factor: 4.207

Review 3.  Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives.

Authors:  Jianan Zhao; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2022-08-04       Impact factor: 8.786

4.  A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma.

Authors:  Xiao-Mao Tian; Bin Xiang; Yi-Hang Yu; Qi Li; Zhao-Xia Zhang; Chenghao Zhanghuang; Li-Ming Jin; Jin-Kui Wang; Tao Mi; Mei-Lin Chen; Feng Liu; Guang-Hui Wei
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

5.  Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis.

Authors:  Snehal Nirgude; Sagar Desai; Bibha Choudhary
Journal:  Cancer Rep (Hoboken)       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.